The Pharmaceutical Research and Manufacturers of America (PhRMA) has named Anne Esposito as its new senior vice president of federal advocacy, effective January 2020, it was reported yesterday.
Esposito will manage the association's federal government affairs and succeeds Scott Olsen, who is retiring.
Esposito is a seasoned government relations strategist with more than 20 years of policy and political expertise in the public and private sector. Following several years at the United States Department of Health and Human Services, she went to Capitol Hill where she advised members of Congress on health policy and other issues. She has held leadership positions at several large and small biopharmaceutical companies, and most recently served as vice president of global government affairs for Indivior Inc. She is a past president and member of Women in Government Relations.
TiumBio files Clinical Trial Application to start Phase 1b TU7710 study
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval